-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Immunocore Holdings plc quarterly/annual Cost of Revenue history and growth rate from Q1 2023 to Q2 2024.
- Immunocore Holdings plc Cost of Revenue for the quarter ending June 30, 2024 was $1.71M, a 393% increase year-over-year.
- Immunocore Holdings plc annual Cost of Revenue for 2023 was $1.04M, a 4.78% decline from 2022.
- Immunocore Holdings plc annual Cost of Revenue for 2022 was $1.09M.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)